Introduction Thyroid diseases are common in some metabolic disorders, such as diabetes mellitus (DM) and obesity
(12) M Macvanin, Z Gluvic, J Radovanovic, M Essack, et al (2023) New insights on the cardiovascular effects of IGF-1 Frontiers in Endocrinology (Lausanne), 2023 Feb 9, Volume 14, Page 1142644
Nothing here should be taken as a promise of specific results, and no dosing information should be used to self-treat
This guide is educational and does not replace an in-person surgical assessment
The medication works by activating GLP-1 receptors throughout the digestive tract, which alters gut motility and slows gastric emptying